Liraglutide Decreases Postprandial Fibroblast Growth Factor 19 And Glucagon-Like Peptide 2, And Increases Postprandial Cholecystokinin In Individuals With ObesityA. Bronden, H. H. Nerild, C. C. Nexoe-Larsen, P. H. Hellmann, M. Baekdal, I. M. Gether,M. P. Gillum, B. Hartmann,L. B. Knudsen, L. V. Jacobsen,J. F. Rehfeld,J. J. Holst, T. Vilsboll,D. P. Sonne,F. K. KnopDIABETOLOGIA（2021）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
